About this trial
To compare the clinical effectiveness of ultrasound-guided versus arthroscopic guided platelet rich fibrin injection in the management of anterior disc displacement with reduction of the temporomandibular joint, in terms of pain reduction, improvement of mandibular function, and patient-reported outcomes.
Eligibility criteria
Qualifiers
Patients aged 18-60 years.
Clinically and radiographically diagnosed temporomandibular joint disc displacemet with reduction.
Presence of TMJ pain exacerbated by mandibular movement.
Limited mandibular function and/or reduced maximum mouth opening.
Disqualifiers
Previous TMJ surgery or arthroscopic intervention.
Intra-articular injection in the TMJ within the last 6 months.
Systemic inflammatory or autoimmune joint diseases.
Coagulation disorders or current anticoagulant therapy.
Trial design
Treatments tested in this trial
- ultrasound guided platelet rich fibrin injection
- Arthroscopic guided platelet rich Fibrin injection